ECRG2 Regulates Cell Migration/Invasion through Urokinase-type Plasmin Activator Receptor (uPAR)/β1 Integrin Pathway
Authors:
Open Access
- 1 November 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (45) , 30897-30906
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ECRG2 Disruption Leads to Centrosome Amplification and Spindle Checkpoint Defects Contributing Chromosome InstabilityJournal of Biological Chemistry, 2008
- ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activityCarcinogenesis, 2007
- Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and αvβ5 integrinJournal of Cell Science, 2006
- Monoclonal Antibodies to Esophageal Cancer–Related Gene2 ProteinHybridoma, 2005
- Regulation of α5β1 integrin conformation and function by urokinase receptor bindingJournal of Cell Biology, 2005
- Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinaseJournal of Biological Chemistry, 2004
- Maspin – the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer – is strongly expressed in preneoplastic bronchial lesionsOncogene, 2003
- GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxisJournal of Cell Biology, 2003
- Tumour-cell invasion and migration: diversity and escape mechanismsNature Reviews Cancer, 2003
- Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrinsJournal of Cell Biology, 2003